
TargetMol develops bioactive compounds, compound libraries, recombinant proteins and biochemical research products for drug discovery and life science research.
Its portfolio is especially relevant to laboratories working on target validation, signaling pathways, phenotypic screening, high-throughput screening and preclinical drug development.
Small-molecule inhibitors are a major part of the TargetMol portfolio. Products cover enzymes, receptors, ion channels, transporters and intracellular signaling proteins.
Available compound types include:
Researchers should confirm the mechanism of action, target selectivity, biochemical potency and cell-based activity before selecting a compound.
Reported IC₅₀, EC₅₀ and Kd values may vary between assays because experimental conditions, substrates and cell models are different.
TargetMol products cover many established and emerging biological pathways, including:
Researchers can search for compounds by target, pathway, disease area or biological effect.
A compound assigned to a pathway may affect several proteins or cellular processes, so pathway classification should not be treated as proof of complete specificity.
TargetMol supplies compound libraries for high-throughput screening, drug repurposing and functional research.
Library types include:
Libraries may be supplied in microplates or tubes and dissolved in DMSO or another specified solvent.
Customers should confirm the compound number, concentration, volume, solvent, plate type, well layout and storage conditions.
Approved-drug libraries are commonly used for drug-repurposing and phenotypic screening projects.
They allow researchers to evaluate compounds with known clinical or pharmacological histories in new disease models.
However, the inclusion of a compound in an approved-drug library does not mean that it is approved for the customer’s proposed research application, dose or disease indication.
The regulatory status of individual compounds can also differ between countries.
TargetMol supplies natural compounds and natural-product libraries derived from plants, microorganisms and other biological sources.
Product categories may include:
Natural products may have multiple biological targets. Purity, source and structural confirmation should therefore be reviewed before use.
For cell-based experiments, solubility and vehicle concentration require careful optimization.
The portfolio includes products for targeted protein degradation research.
Relevant products include:
PROTAC activity depends on ternary-complex formation, target expression and the availability of the selected E3 ligase.
A compound’s degradation concentration and maximum degradation effect may provide more useful information than binding affinity alone.
TargetMol provides metabolites, impurities and reference compounds for pharmacology and metabolism studies.
These products may support:
Customers should distinguish between research compounds and certified analytical reference materials. Not every high-purity compound is supplied with metrologically traceable certification.
TargetMol supplies recombinant cytokines, growth factors, receptors, enzymes and drug-target proteins.
Applications include:
Before ordering, confirm the species, expression system, tag, purity, endotoxin level and biological activity.
Proteins used with living cells may require sterile preparation and low endotoxin levels.
The TargetMol portfolio includes bioactive peptides, peptide hormones, peptide inhibitors and selected custom peptide services.
Peptides may be used for:
Customers should review peptide purity, sequence, salt form, molecular weight and solubility.
Peptide adsorption to plastic surfaces can become significant at low concentrations, so suitable tubes and carrier proteins may be required.
TargetMol products support research in:
Disease-area classifications are useful for product discovery, but final compound selection should be based on the experimental target and mechanism.
Oncology-related products cover kinases, apoptosis regulators, DNA-damage pathways, immune checkpoints and tumor metabolism.
Typical research targets include:
Researchers should confirm whether a compound acts directly on the selected target or affects it indirectly through an upstream pathway.
Products for immune and inflammatory research include modulators of cytokines, pattern-recognition receptors and immune-cell signaling pathways.
Relevant target groups include:
When studying immune responses, researchers should evaluate cytotoxicity separately from the intended immunomodulatory effect.
TargetMol supplies compounds for neurodegeneration, neurotransmission, ion-channel research and neurological disease models.
Research areas include:
For in vivo neuroscience studies, blood–brain barrier penetration and pharmacokinetic information may be important selection criteria.
Small-molecule performance depends heavily on correct preparation.
Before an experiment, researchers should confirm:
DMSO stock solutions should normally be divided into small aliquots to reduce repeated freeze–thaw cycles.
Precipitation may occur when a concentrated DMSO stock is diluted into an aqueous medium, even if the stock initially appears clear.
Product documentation may include:
Customers requiring a particular analytical method or purity threshold should review the lot-specific certificate rather than relying only on the general product-page specification.
TargetMol may provide custom synthesis, compound sourcing, library configuration and plate preparation.
A custom request should define:
For screening libraries, customers should also specify plate type, well position and whether control wells are required.
Customers should provide the complete catalog number, compound name, package size and quantity when requesting a quotation.
For cell experiments, confirm compound solubility, vehicle tolerance and cytotoxicity. For animal studies, formulation, route of administration and available pharmacokinetic information should be reviewed.
The same compound may be available in several purity levels, salt forms or package sizes. These should not be treated as interchangeable without checking the product documentation.
TargetMol compounds and proteins are primarily supplied for research use only. They are not intended for human or veterinary treatment, clinical diagnosis or direct administration unless specifically stated.
Official website link: